Setting the Standard for NAD+ Restoration in Regulated Markets
CellVive NMN™ has been recommended for inclusion in the Australian Therapeutic Goods Administration (TGA) Permissible Ingredient Determination.
Set to become Australia's Only Regulated & Validated Nicotinamide Mononucleotide (NMN)
Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and related to vitamin B₃. It plays a key role as a direct precursor to NAD⁺ (Nicotinamide Adenine Dinucleotide), which is an essential coenzyme involved in energy metabolism and many cellular functions. Science has demonstrated that NAD⁺ levels naturally decline with age, causing age related diseases. NMN has become a focus of scientific research for its role in supporting this vital pathway.
Pharmaceutical-Standard Purity and Process
CellVive NMN™ delivers ≥99% purity through pharmaceutical-standard manufacturing, ensuring unmatched consistency, stability, and quality assurance.
Backed by over 15 clinical trials and Australian university partnerships, CellVive NMN™ delivers proven NAD⁺ elevation and evidence-based benefits for energy, repair, and cellular resilience.
Available solely through Longevity Life Sciences, CellVive NMN™ combines guaranteed supply assurance with collaborative scientific and regulatory support.
Cellvive NMN™ is produced to the same stringent standards as pharmaceutical ingredients, offering the scientific credibility and compliance today’s longevity market demands.
Our Partners
